Skip to main content
OpenTrials
Completed

NCT Number: NCT07155785

The Role of Lidocaine Spray in Reducing Pain During Intrauterine Device Application

Investigators aimed to investigate the effectiveness of the use of local lidocaine spray application to make routine intrauterine intrauterine device application more painless.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul Medeniyet University

Istanbul, Turkey (Türkiye)

About this study

As a standard, no anaesthesia is applied to the patient during intrauterine device application in outpatient clinic conditions. Patients can usually tolerate the procedure even if there is minimal pain and discomfort. In patients with low pain tolerance, the procedure can be terminated before the application can be performed and the application can be repeated under local or general anaesthesia. Local anaesthetic sprays are routinely and comfortably used in episiotomy repair, upper gastrointestinal tract endoscopy and intraoral procedures. In our study, investigators aimed to demonstrate the efficacy of local spray anaesthesia without side effects for the relief of pain that occurs in some patients during intrauterine device application by comparing it with placebo.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-45 years old patient who comes to have an intrauterine device inserted voluntarily
  • The patient who gave consent to participate in the study

Exclusion criteria

  • Patients who cannot have an intrauterine device because of fibroids or cervical stenosis
  • Patient who did not want to participate in the study

Treatment and study plan

Lidocain spray

Drug

Lidocaine spray as a local anaesthetic agent was applied to the cervix before intrauterine device application.

Primary outcomes

  1. Pain component

    Time frame: 1 hour

    Reduction of the pain felt during application of the intrauterine device

Sponsors and collaborators

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Other

Registry information

Acronym: Lidocaine IUD

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Sep 4, 2025
Registry last updated
Sep 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.